The high-throughput screening (HTS) market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market.
The global high-throughput screening (HTS) market size is projected to reach USD 26.4 billion by 2025 from USD
15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950
Scope
of the Report
This report categorizes the high-throughput
screening market into the following segments and subsegments:
High-throughput
screening Market, by Product & Service
- Consumables
- Reagents & Assay Kits
- ;Laboratory Equipment
- Instruments
- Liquid Handling Systems
- Detection Systems
- Other Instruments
- Services
- Software
High-throughput
Screening Market, by Technology
- Cell-based Assays
- 2D Cell Culture
- 3D Cell Culture
- Scaffold-based Technology
- Hydrogels
- Animal-derived Hydrogels
- Matrigel
- Collagen
- Synthetic Hydrogels
- Alginate/Agarose
- Inert Matrix/Solid Scaffolds
- Micropatterned Surfaces
- Scaffold-free Technology
- Ultra-low Binding Plates
- Hanging-drop Plates
- Other Scaffold-free Technologies
- Reporter-based Assays
- Perfusion Cell Culture
- Lab-on-a-Chip Technology (LOC)
- Label-free Technology
High-throughput
Screening Market, by Application
- Drug Discovery
- Biochemical Screening
- Life Sciences Research
- Other Applications
High-throughput
Screning Market, by End User
- Pharmaceutical &
Biotechnology Companies
- Academic & Research
Institutes
- Contract Research Organizations
(CROs)
- Other End Users
High-throughput
Screning Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- Japan
- China
- India
- Australia
- Rest of Asia Pacific (RoAPAC)
- Rest of the World (RoW)
- Latin America
- Middle East and Africa
Market Segmentation:
On the basis type of product & service, the HTS
Market is broadly segmented into consumables , instruments, services, and
software. In 2019, consumables accounted for the largest share of the
high-throughput screening (HTS) market. This can primarily be attributed to the
wide use of reagents & assay kits in HTS techniques, increasing
pharmaceutical R&D, and rising government funding for life sciences
research.
Based on application, the HTS Market is categorized
into four segments—drug discovery, biochemical screening, life sciences, and
other applications. The drug discovery application segment accounted for the
largest share of the market in 2019. The key factor driving this segments
growth is the increasing number of clinical trials and rising pharmaceutical
R&D expenditure.
Regional Analysis:
In 2019, Asia
Pacific region accounted for the fastest-growing
region of the HTS Market. It is also estimated to grow at the highest CAGR in
the market during the forecast period, this is mainly due to factors such as
the rising R&D spending, growing public-private partnerships, and
increasing government funding are factors driving the growth of the market in
this region.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950
Top Key Players:-
Some of the prominent players in the high-throughput
screening market are Thermo Fisher Scientific Inc. (US), Agilent
Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US),
Tecan Group Ltd. (Switzerland),
AXXAM S.p.A. (Italy),
Merck KGaA (Germany),
Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated
(US), and Eurofins Scientific (Luxembourg).
No comments:
Post a Comment